WANG Juan,YANG Yating,ZHANG Yulong, et al. Relationship between IL-17 Level and Glycolipid Metabolism in Patients with Chronic Schizophrenia [J]. Chinese General Practice, 2021, 24(3): 304-310. DOI: 10.12114/j.issn.1007-9572.2020.00.493.
王娟,杨亚婷,张雨龙等. 慢性精神分裂症患者血浆白介素17与糖脂代谢的相关性研究[J]. 中国全科医学, 2021, 24(3): 304-310. DOI: 10.12114/j.issn.1007-9572.2020.00.493.
[1]BITTER I,CZOBOR P,BORSI A,et al.Mortality and the relationship of somatic comorbidities to mortality in schizophrenia.A nationwide matched-cohort study[J].Eur Psychiatr,2017,45:97-103.DOI:10.1016/j.eurpsy.2017.05.022.
[2]World Health Organization.Schizophrenia[EB/OL].[2020-04.03].http://www.who.int/mediacentre/factsheets/fs397/en/.
[3]CHAN K Y,ZHAO F F,MENG S J,et al.Urbanization and the prevalence of schizophrenia in China between 1990 and 2010[J].World Psychiatry,2015,14(2):251-252.DOI:10.1002/wps.20222.
[4]BETTELLI E,KORN T,OUKKA M,et al.Induction and effector functions of TH17 cells[J].Nature,2008,453(7198):1051-1057.DOI:10.1038/nature07036.
[5]施沛青,朱书,钱友存.IL-17的信号传导及功能研究[J].中国细胞生物学学报,2011,33(4):345-357.
SHI P Q,ZHU S,QIAN Y Q.IL-17 signaling and function[J].Chinese Journal of Cell Biology,2011,33(4):345-357.
[6]HOTAMISLIGIL G S.Inflammation and metabolic disorders[J].Nature,2006,444(7121):860-867.DOI:10.1038/nature05485.
[7]CALLE M C,FERNANDEZ M L.Inflammation and type 2 diabetes[J].Diabetes Metab,2012,38(3):183-191.DOI:10.1016/j.diabet.2011.11.006.
[8]ABDEL-MONEIM A,BAKERY H H,ALLAM G.The potential pathogenic role of IL-17/Th17 cells in both type 1 and type 2 diabetes mellitus[J].Biomed Pharmacother,2018,101:287-292.DOI:10.1016/j.biopha.2018.02.103.
[9]SHOELSON S E.Inflammation and insulin resistance[J].J Clin Investig,2006,116(7):1793-1801.DOI:10.1172/jci29069.
[10]宁晓帅,夏磊,杨亚婷,等.慢性精神分裂症患者胰岛素抵抗水平与血浆超敏C反应蛋白的关系[J].中华行为医学与脑科学杂志,2019,28(9):822-826.DOI:10.3760/cma.j.issn.1674-6554.2019.09.012.
NING X S,XIA L,YANG Y T,et al.The relationship between insulin resistance and plasma hs-CRP in patients with chronic schizophrenia[J].Chin J Behav Med & Brain Sci,2019,28(9):822-826.DOI:10.3760/cma.j.issn.1674-6554.2019.09.012.
[11]李文正,夏磊,张雨龙,等.慢性精神分裂症血脂代谢特征及其与HS-CRP的关系[J].安徽医科大学学报,2019,54(12):1975-1979.DOI:10.19405/j.cnki.issn1000-1492.2019.12.028.
LI W Z,XIA l,ZHANG Y L,et al.Characteristic of lipid metabolism in chronic schizophrenia and its relationship with HS-CRP[J].Acta Universitatis Medicinalis Anhui,2019,54(12):1975-1979.DOI:10.19405/j.cnki.issn1000-1492.2019.12.028.
[12]姚献虎,夏磊,李文正,等.精神分裂症患者伴发代谢综合征与超敏C反应蛋白水平的相关研究[J].中国全科医学,2020,23(3):294-298,304.DOI:10.12114/j.issn.1007-9572.2019.00.710.
YAO X H,XIA L,LI W Z,et al.Association between metabolic syndrome and the level of high-sensitivity C-reactive protein in patients with schizophrenia[J].Chinese General Practice,2020,23(3):294-298,304.DOI:10.12114/j.issn.1007-9572.2019.00.710.
[13]李文正,夏磊,郝蕊,等.氯氮平导致胰腺炎作用机制的研究进展[J].中国全科医学,2019,22(26):3246-3250.DOI:10.12114/j.issn.1007-9572.2019.00.101.
LI W Z,XIA L,HAO R,et al.Progress in the Mechanism of Pancreatitis Associated with Clozapine[J].Chinese General Practice,2019,22(26):3246-3250.DOI:10.12114/j.issn.1007-9572.2019.00.101.
[14]FULLER TORREY E,PETERSON M.Slow and latent viruses in schizophrenia[J].Lancet,1973,302(7819):22-24.DOI:10.1016/s0140-6736(73)91952-1.
[15]DEBNATH M,BERK M.Functional implications of the IL-23/IL-17 immune axis in schizophrenia[J].Mol Neurobiol,2017,54(10):8170-8178.DOI:10.1007/s12035-016-0309-1.
[16]PARK H,LI Z X,YANG X O,et al.A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17[J].Nat Immunol,2005,6(11):1133-1141.DOI:10.1038/ni1261.
[17]EL KISSI Y,SAMOUD S,MTIRAOUI A,et al.Increased Interleukin-17 and decreased BAFF serum levels in drug-free acute schizophrenia[J].Psychiatry Res,2015,225(1/2):58-63.DOI:10.1016/j.psychres.2014.10.007.
[18]BOCCHIO-CHIAVETTO L,ZANARDINI R,TOSATO S,et al.Immune and metabolic alterations in first episode psychosis(FEP) patients[J].Brain Behav Immun,2018,70:315-324.DOI:10.1016/j.bbi.2018.03.013.
[19]孙志刚,李素水,范彦蓉,等.未服药精神分裂症患者血清IL-2、IL-4、IL-6、IL-10和IL-17A的水平[J].中国建康心理学杂志,2019,27(1):1-3.DOI:10.13342/j.cnki.cjhp.2019.01.001.
SUN Z G,LI S S,FAN Y R,et al.The levels of IL-2,IL-4,IL-6,IL-10,and IL-17A in serum of medication naive patients with schizophrenia[J].China Journal of Health Psychology,2019,27(1):1-3.doi:10.13342/j.cnki.cjhp.2019.01.001.
[20]李庆,徐金玲,方红娟,等.妊娠期糖尿病患者血清IL-17、IL-1β、IL-10水平变化及其与胰岛素抵抗、血脂的关系[J].山东医药,2019,59(4):52-54.DOI:10.3969/j.issn.1002-266X.2019.04.013.
LI Q,X J L,FANG H J,et al.Changes of serum IL- 17,IL-1β,IL-10 levels and their relationship with insulin resistance and blood lipids in patients with gestational diabetes mellitus[J].Shandong Medicine,2019,59(4):52-54.DOI:10.3969/j.issn.1002-266X.2019.04.013.
[21]张倩辉,谢悦陶,党懿,等.IL-17A启动子基因多态性与冠心病患者血脂和炎症因子的关联性研究[J].重庆医学,2018,47(11):1457-1464.DOI:10.3969/j.issn.1671-8348.2018.11.007.
ZHANG Q H,XIE Y T,DANG Y,et al.Association of IL-17 A gene promoter polymorphism with blood lipid a inflammatory factors in patients with coronary heart disease[J].Chongqing medicine,2018,47(11):1457-1464.DOI:10.3969/j.issn.1671-8348.2018.11.007.
[22]JAHROMI A S,SHOJAEI M,GHOBADIFAR M A.Insulin resistance and serum levels of interleukin-17 and interleukin-18 in normal pregnancy[J].Immune Netw,2014,14(3):149.DOI:10.4110/in.2014.14.3.149.
[23]CHEN C H,SHAO Y B.Elevated interleukin-17 levels in patients with newly diagnosed type 2 diabetes mellitus[J].Biochem Physiol:Open Access,2016,5(2):2.DOI:10.4172/2168-9652.1000206.
[24]OHSHIMA K,MOGI M,JING F,et al.Roles of interleukin 17 in angiotensin II type 1 receptor-mediated insulin resistance[J].Hypertension,2012,59(2):493-499.DOI:10.1161/hypertensionaha.111.183178.
[25]TSAI S,CLEMENTE-CASARES X,REVELO X S,et al.Are obesity-related insulin resistance and type 2 diabetes autoimmune diseases?[J].Diabetes,2015,64(6):1886-1897.DOI:10.2337/db14-1488.
[26]ZEPP J,WU L,LI X X.IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease[J].Trends Immunol,2011,32(5):232-239.DOI:10.1016/j.it.2011.02.007.
[27]MATTHEWS D R,HOSKER J P,RUDENSKI A S,et al.Homeostasis model assessment:insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man[J].Diabetologia,1985,28(7):412-419.DOI:10.1007/bf00280883.
[28]MANTI S,LEONARDI S,PANASITI I,et al.Serum IL-10,IL-17 and IL-23 levels as “bioumoral bridges” between dyslipidemia and atopy[J].Cytokine,2017,99:43-49.DOI:10.1016/j.cyto.2017.07.002.
[29]SURENDAR J,ARAVINDHAN V,RAO M M,et al.Decreased serum interleukin-17 and increased transforming growth factor–β levels in subjects with metabolic syndrome(Chennai Urban Rural Epidemiology Study-95)[J].Metabolism,2011,60(4):586-590.DOI:10.1016/j.metabol.2010.06.003.
[30]ELJAAFARI A,ROBERT M,CHEHIMI M,et al.Adipose tissue-derived stem cells from obese subjects contribute to inflammation and reduced insulin response in adipocytes through differential regulation of the Th1/Th17 balance and monocyte activation[J].Diabetes,2015,64(7):2477-2488.DOI:10.2337/db15-0162.
[31]NIKOOPOUR E,SCHWARTZ J A,HUSZARIK K,et al.Th17 polarized cells from nonobese diabetic mice following mycobacterial adjuvant immunotherapy delay type 1 diabetes[J].J Immunol,2010,184(9):4779-4788.DOI:10.4049/jimmunol.0902822.